Advertisement
Advertisement
LFCR
Lifecore Biomedical, Inc. Common Stock
6.37
USDSponsored
0.00
0.00%
Nov 10, 15:55 UTC -5
Closed
After-Market
6.38
0.00
+0.08%
Lifecore Biomedical, Inc. Common Stock (LFCR) Earnings
LFCR Earnings Reports
Positive Surprise Ratio
LFCR beat 21 of 38 last estimates.
55%
Next Report
Date of Next Report
Feb 05, 2027
Estimate for Q4 26 (Revenue/ EPS)
$38.54M
/-$0.10
Implied change from Q3 26 (Revenue/ EPS)
+52.21%
/-90.74%
Implied change from Q4 25 (Revenue/ EPS)
+5.76%
/+66.67%
Lifecore Biomedical, Inc. Common Stock earnings per share and revenue
On Nov 04, 2026, LFCR reported earnings of -1.08 USD per share (EPS) for Q3 26, missing the estimate of -0.30 USD, resulting in a -255.85% surprise. Revenue reached 25.32 million, compared to an expected 27.23 million, with a -7.02% difference. The market reacted with a +0.31% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 7 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 38.54 million USD, implying an decrease of -90.74% EPS, and increase of 52.21% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kura Oncology, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.83
Actual
-$0.78
Surprise
+7.00%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.63
Actual
-$0.73
Surprise
-14.53%
Autolus Therapeutics plc - ADR
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.21
Surprise
-27.20%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.03
Actual
$0.05
Surprise
+265.02%
PepGen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.19%
Humacyte, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+22.91%
Seer, Inc. Class A Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.25
Surprise
+1.96%
Scholar Rock Holding Corporation Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.81
Surprise
+6.18%
TELA Bio, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.13
Surprise
+20.54%
Atossa Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.90
Actual
-$0.56
Surprise
+38.31%
FAQ
What were Lifecore Biomedical, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Lifecore Biomedical, Inc. Common Stock reported EPS of -$1.08, missing estimates by -255.85%, and revenue of $25.32M, -7.02% below expectations.
How did the market react to Lifecore Biomedical, Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 0.31%, changed from $6.42 before the earnings release to $6.44 the day after.
When is Lifecore Biomedical, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 05, 2027.
What are the forecasts for Lifecore Biomedical, Inc. Common Stock's next earnings report?
Based on 7
analysts, Lifecore Biomedical, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $38.54M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.